Literature DB >> 30520820

Cholangiolocellular Carcinoma With "Ductal Plate Malformation" Pattern May Be Characterized by ARID1A Genetic Alterations.

Motoko Sasaki1, Yasunori Sato1, Yasuni Nakanuma1,2.   

Abstract

Cholangiolocellular carcinoma (CLC) is a unique subtype of primary liver carcinoma, which sometimes coexists with hepatocellular carcinoma (HCC), cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma (cHCC-CCA). "Ductal plate malformation" (DPM)-pattern of primary liver carcinoma, which resembles biliary lesions in Caroli disease and von Meyenburg complex, is sometimes associated with CLC. We examined genetic alterations of hTERT promoter (hTERT), IDH1 or 2 (IDH1/2), KRAS, ARID1A, PBRM1, ARID2, BAP1, p53 and their association with histologic features such as proportion of CLC and DPM-pattern in 77 patients with primary liver carcinoma diagnosed as cHCC-CCA or CLC. Primary liver carcinomas were histologically subdivided into 29 CLC-predominant (CLC component >80%), 31 with CLC (5% to 80%) and 17 without CLC (<5%). CLC-predominant group was characterized by older age, male-predominant and smaller tumor size. Genetic alterations were detected in hTERT (25%), ARID1A (21%), PBRM1 (20%), ARID2 (3%), BAP1 (1%), p53 (46%), KRAS (5%), and IDH1/2 (8%). ARID1A alteration was more frequent in CLC-predominant group, compared with other groups (P<0.05) and was correlated with the degree of DPM-pattern (P<0.01). Alterations of hTERT and p53 were less frequent in CLC-predominant group compared with "with CLC group" (P<0.05). hTERT mutation was less frequent in carcinomas with DPM-pattern (P<0.01). PBRM1 alteration was more frequent in CLC with focal HCC subgroup and without CLC group compared with other groups (P<0.05). CLC may be a distinct subgroup of primary liver carcinoma, which is different from cHCC-CCA, based on clinicopathologic and genetic alterations. ARID1A alterations may characterize CLC with DPM-pattern and could be a diagnostic immunohistochemical marker for small CLCs with DPM-pattern.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30520820     DOI: 10.1097/PAS.0000000000001201

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  6 in total

1.  Distinct histomorphological features are associated with IDH1 mutation in intrahepatic cholangiocarcinoma.

Authors:  Tao Wang; Esther Drill; Efsevia Vakiani; Linda Ma Pak; Thomas Boerner; Gokce Askan; Juan Manuel Schvartzman; Amber L Simpson; William R Jarnagin; Carlie S Sigel
Journal:  Hum Pathol       Date:  2019-05-21       Impact factor: 3.466

2.  Genetic, Clinicopathological, and Radiological Features of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern.

Authors:  Taek Chung; Hyungjin Rhee; Hyo Sup Shim; Jeong Eun Yoo; Gi Hong Choi; Haeryoung Kim; Young Nyun Park
Journal:  Gut Liver       Date:  2021-11-23       Impact factor: 4.321

Review 3.  Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma.

Authors:  Taek Chung; Young Nyun Park
Journal:  Front Med (Lausanne)       Date:  2022-03-31

Review 4.  ARID1A Variations in Cholangiocarcinoma: Clinical Significances and Molecular Mechanisms.

Authors:  Shankun Zhao; Youwen Xu; Weizhou Wu; Pan Wang; Yichao Wang; Hao Jiang; Jie Zhu
Journal:  Front Oncol       Date:  2021-06-25       Impact factor: 6.244

5.  Role of ARID1A in epithelial‑mesenchymal transition in breast cancer and its effect on cell sensitivity to 5‑FU.

Authors:  Tangshun Wang; Xiang Gao; Kexin Zhou; Tao Jiang; Shuang Gao; Pengzhou Liu; Ximeng Zuo; Xiaoguang Shi
Journal:  Int J Mol Med       Date:  2020-09-15       Impact factor: 4.101

Review 6.  Pathological, molecular, and clinical characteristics of cholangiocarcinoma: A comprehensive review.

Authors:  Mukul Vij; Yogesh Puri; Ashwin Rammohan; Gowripriya G; Rajesh Rajalingam; Ilankumaran Kaliamoorthy; Mohamed Rela
Journal:  World J Gastrointest Oncol       Date:  2022-03-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.